Logo image of MRAM

EVERSPIN TECHNOLOGIES INC (MRAM) Stock Fundamental Analysis

NASDAQ:MRAM - US30041T1043 - Common Stock

6.39 USD
-0.12 (-1.84%)
Last: 8/27/2025, 8:05:37 PM
Fundamental Rating

5

MRAM gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. No worries on liquidiy or solvency for MRAM as it has an excellent financial health rating, but there are worries on the profitability. MRAM has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

MRAM had positive earnings in the past year.
In the past year MRAM had a positive cash flow from operations.
Of the past 5 years MRAM 4 years were profitable.
MRAM had a positive operating cash flow in 4 of the past 5 years.
MRAM Yearly Net Income VS EBIT VS OCF VS FCFMRAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

MRAM has a Return On Assets (2.09%) which is comparable to the rest of the industry.
MRAM has a Return On Equity of 2.57%. This is comparable to the rest of the industry: MRAM outperforms 54.55% of its industry peers.
Industry RankSector Rank
ROA 2.09%
ROE 2.57%
ROIC N/A
ROA(3y)8.51%
ROA(5y)2.08%
ROE(3y)11.3%
ROE(5y)0.19%
ROIC(3y)N/A
ROIC(5y)N/A
MRAM Yearly ROA, ROE, ROICMRAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600 -800

1.3 Margins

With a Profit Margin value of 3.19%, MRAM perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
In the last couple of years the Profit Margin of MRAM has declined.
MRAM's Gross Margin of 50.84% is fine compared to the rest of the industry. MRAM outperforms 63.64% of its industry peers.
MRAM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 3.19%
GM 50.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-41.82%
PM growth 5YN/A
GM growth 3Y-4.74%
GM growth 5Y1.18%
MRAM Yearly Profit, Operating, Gross MarginsMRAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

8

2. Health

2.1 Basic Checks

MRAM does not have a ROIC to compare to the WACC, probably because it is not profitable.
MRAM has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MRAM has been increased compared to 5 years ago.
MRAM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MRAM Yearly Shares OutstandingMRAM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
MRAM Yearly Total Debt VS Total AssetsMRAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 4.54 indicates that MRAM is not in any danger for bankruptcy at the moment.
MRAM has a Altman-Z score of 4.54. This is in the better half of the industry: MRAM outperforms 61.82% of its industry peers.
There is no outstanding debt for MRAM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.54
ROIC/WACCN/A
WACC11.71%
MRAM Yearly LT Debt VS Equity VS FCFMRAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

MRAM has a Current Ratio of 5.87. This indicates that MRAM is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 5.87, MRAM belongs to the top of the industry, outperforming 82.73% of the companies in the same industry.
MRAM has a Quick Ratio of 4.85. This indicates that MRAM is financially healthy and has no problem in meeting its short term obligations.
MRAM has a better Quick ratio (4.85) than 83.64% of its industry peers.
Industry RankSector Rank
Current Ratio 5.87
Quick Ratio 4.85
MRAM Yearly Current Assets VS Current LiabilitesMRAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for MRAM have decreased by -3.71% in the last year.
The Earnings Per Share has been decreasing by -4.88% on average over the past years.
MRAM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.28%.
Measured over the past years, MRAM shows a small growth in Revenue. The Revenue has been growing by 6.09% on average per year.
EPS 1Y (TTM)-3.71%
EPS 3Y-4.88%
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)-11.28%
Revenue growth 3Y-2.96%
Revenue growth 5Y6.09%
Sales Q2Q%24.12%

3.2 Future

The Earnings Per Share is expected to grow by 96.73% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 11.84% on average over the next years. This is quite good.
EPS Next Y-45.41%
EPS Next 2Y4.26%
EPS Next 3Y96.73%
EPS Next 5YN/A
Revenue Next Year10.27%
Revenue Next 2Y11.84%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MRAM Yearly Revenue VS EstimatesMRAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
MRAM Yearly EPS VS EstimatesMRAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.79, which indicates a rather expensive current valuation of MRAM.
MRAM's Price/Earnings ratio is rather cheap when compared to the industry. MRAM is cheaper than 82.73% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.14. MRAM is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 17.98, MRAM is valued on the expensive side.
76.36% of the companies in the same industry are more expensive than MRAM, based on the Price/Forward Earnings ratio.
MRAM's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.80.
Industry RankSector Rank
PE 18.79
Fwd PE 17.98
MRAM Price Earnings VS Forward Price EarningsMRAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

MRAM's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MRAM is cheaper than 84.55% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.47
EV/EBITDA N/A
MRAM Per share dataMRAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

A more expensive valuation may be justified as MRAM's earnings are expected to grow with 96.73% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.26%
EPS Next 3Y96.73%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MRAM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EVERSPIN TECHNOLOGIES INC

NASDAQ:MRAM (8/27/2025, 8:05:37 PM)

6.39

-0.12 (-1.84%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)10-28 2025-10-28
Inst Owners65.07%
Inst Owner Change-3.74%
Ins Owners4.8%
Ins Owner Change2.59%
Market Cap144.61M
Analysts82.5
Price Target8.67 (35.68%)
Short Float %1.77%
Short Ratio2.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)612.42%
Min EPS beat(2)17.65%
Max EPS beat(2)1207.19%
EPS beat(4)4
Avg EPS beat(4)770.67%
Min EPS beat(4)17.65%
Max EPS beat(4)1766.67%
EPS beat(8)8
Avg EPS beat(8)402.05%
EPS beat(12)12
Avg EPS beat(12)305.89%
EPS beat(16)16
Avg EPS beat(16)685.42%
Revenue beat(2)1
Avg Revenue beat(2)1.3%
Min Revenue beat(2)-0.44%
Max Revenue beat(2)3.04%
Revenue beat(4)2
Avg Revenue beat(4)1.32%
Min Revenue beat(4)-1.2%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)1.01%
Revenue beat(12)9
Avg Revenue beat(12)1.45%
Revenue beat(16)13
Avg Revenue beat(16)3.03%
PT rev (1m)-5.56%
PT rev (3m)-5.56%
EPS NQ rev (1m)-11.11%
EPS NQ rev (3m)-55.56%
EPS NY rev (1m)2.94%
EPS NY rev (3m)2.94%
Revenue NQ rev (1m)2.56%
Revenue NQ rev (3m)2.56%
Revenue NY rev (1m)1.2%
Revenue NY rev (3m)1.2%
Valuation
Industry RankSector Rank
PE 18.79
Fwd PE 17.98
P/S 2.8
P/FCF 19.47
P/OCF 11.02
P/B 2.26
P/tB 2.35
EV/EBITDA N/A
EPS(TTM)0.34
EY5.32%
EPS(NY)0.36
Fwd EY5.56%
FCF(TTM)0.33
FCFY5.14%
OCF(TTM)0.58
OCFY9.08%
SpS2.28
BVpS2.83
TBVpS2.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.09%
ROE 2.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.19%
GM 50.84%
FCFM 14.37%
ROA(3y)8.51%
ROA(5y)2.08%
ROE(3y)11.3%
ROE(5y)0.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-41.82%
PM growth 5YN/A
GM growth 3Y-4.74%
GM growth 5Y1.18%
F-Score4
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 216.61%
Cap/Sales 11.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 450.39%
Current Ratio 5.87
Quick Ratio 4.85
Altman-Z 4.54
F-Score4
WACC11.71%
ROIC/WACCN/A
Cap/Depr(3y)192.66%
Cap/Depr(5y)132.94%
Cap/Sales(3y)4.31%
Cap/Sales(5y)3.11%
Profit Quality(3y)251.99%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.71%
EPS 3Y-4.88%
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y-45.41%
EPS Next 2Y4.26%
EPS Next 3Y96.73%
EPS Next 5YN/A
Revenue 1Y (TTM)-11.28%
Revenue growth 3Y-2.96%
Revenue growth 5Y6.09%
Sales Q2Q%24.12%
Revenue Next Year10.27%
Revenue Next 2Y11.84%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5211.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year950%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-31.36%
FCF growth 3Y-21.44%
FCF growth 5YN/A
OCF growth 1Y-3.98%
OCF growth 3Y-8.8%
OCF growth 5YN/A